 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Foundations of Cancer Immunotherapy

Introduction to Cancer Immunotherapy and Cellular Therapies

Cancer Immunity and Tumor Immune Evasion

Immune Checkpoint Inhibitors

Principles of Immune Checkpoint Blockade

Clinical Use and Safety Considerations for Checkpoint Inhibitors

CAR-T Cell Therapy and Cellular Therapies

CAR-T Cell Therapy: Components and Mechanism of Action

CAR-T Cell Therapy: Benefits, Limitations, and Toxicities

Bispecific T-Cell Engagers and Related Antibody-Based Therapies

Bispecific T-Cell Engagers: Mechanism and Therapeutic Role

Selecting Between Cellular and T-Cell-Redirecting Approaches

Cancer Vaccines and Emerging Immunotherapy Modalities

Cancer Vaccines: Preventive and Therapeutic Approaches

Emerging Modalities and Combination Immunotherapy

Precision Oncology, Liquid Biopsies, and Next-Generation Sequencing

Next-Generation Sequencing in Precision Oncology

Liquid Biopsies and Personalized Treatment Planning

Integrating Immunotherapy and Precision Oncology Data

Quiz

Question 1: Which immune checkpoint pathway is commonly targeted to restore T-cell activity against cancer cells?

Question 2: What is the primary purpose of engineering T cells in CAR-T cell therapy?

Question 3: How do bispecific T-cell engagers promote anti-cancer activity?

Question 4: Which statement best distinguishes therapeutic cancer vaccines from preventive cancer vaccines?

Question 5: What can circulating tumor DNA in a liquid biopsy help clinicians assess?

Survey and Feedback

Course Feedback Survey

Welcome to the "Principles of Cancer Immunotherapy, Cellular Therapies, and Precision Oncology" course. In recent years, the landscape of oncology has been revolutionized by groundbreaking advancements in how we understand and treat cancer.

Welcome to the "Principles of Cancer Immunotherapy, Cellular Therapies, and Precision Oncology" course. In recent years, the landscape of oncology has been revolutionized by groundbreaking advancements in how we understand and treat cancer. This comprehensive course is designed to provide healthcare professionals, researchers, and students with an in-depth understanding of modern oncological therapies. You will explore the foundational concepts of tumor immunology and discover how cancer cells evade the immune system. From there, we dive deep into the mechanisms, clinical applications, and safety considerations of cutting-edge treatments, including immune checkpoint inhibitors, Chimeric Antigen Receptor (CAR)-T cell therapy, and bispecific T-cell engagers (BiTEs).

Beyond cellular and immune-based therapies, this course demystifies the rapidly evolving field of precision oncology. You will learn how next-generation sequencing (NGS) and liquid biopsies are used to identify actionable genomic alterations, enabling highly personalized treatment plans. We will also cover the development of preventive and therapeutic cancer vaccines and emerging modalities like tumor-infiltrating lymphocytes (TILs). By integrating immunotherapy data with precision oncology, you will be equipped to understand complex clinical scenarios, biomarker results, and the importance of multidisciplinary care. Whether you are looking to update your clinical knowledge or build a strong foundation in modern cancer treatments, this course offers the insights you need to stay at the forefront of oncology.

Principles of Cancer Immunotherapy, Cellular Therapies, and Precision Oncology

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The landscape of modern oncology has undergone a profound transformation with the advent of immune-based and personalized treatment modalities. This course, Principles of Cancer Immunotherapy, Cellular Therapies, and Precision Oncology, provides a comprehensive exploration of how the human immune system can be harnessed and genomic data utilized to effectively target malignancies. The curriculum begins by establishing the foundational mechanisms of anti-tumor immunity and tumor immune evasion, detailing the intricate roles of T cells, antigen-presenting cells, and the tumor microenvironment. By understanding these underlying biological processes, learners will grasp how malignant cells bypass immune surveillance through immunosuppressive signaling and how novel therapeutic interventions are strategically designed to overcome these evasive mechanisms.</p>

<p>Building upon these core biological principles, the program systematically examines the major therapeutic categories that have revolutionized clinical patient care. Detailed modules elucidate the mechanisms of action, clinical applications, and unique safety considerations of immune checkpoint inhibitors, specifically targeting the PD-1, PD-L1, and CTLA-4 pathways. Furthermore, the course delves into the complexities of advanced cellular therapies, prominently featuring Chimeric Antigen Receptor (CAR)-T cell therapy and bispecific T-cell engagers (BiTEs). Learners will compare the engineering processes, administration workflows, and distinct toxicity profiles of these treatments, including critical adverse events such as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. The exploration of immunomodulatory strategies is further broadened through an analysis of preventive and therapeutic cancer vaccines, as well as emerging combination therapies designed to optimize clinical efficacy.</p>

<p>In addition to immunotherapeutic approaches, the course emphasizes the indispensable role of precision oncology in tailoring individualized treatment paradigms. The final sections investigate the clinical utility of next-generation sequencing (NGS) and liquid biopsies in identifying actionable genomic alterations, differentiating between somatic mutations and inherited germline variants, and analyzing circulating tumor DNA (ctDNA). By integrating molecular profiling data with immunotherapy principles, the program illustrates how multidisciplinary teams formulate personalized, biomarker-driven strategies. Ultimately, this rigorous curriculum equips professionals with the analytical framework necessary to navigate the complexities of modern oncological treatments, evaluate predictive biomarkers, and monitor patient outcomes in a rapidly evolving clinical environment.</p>
        </div>
    </div>
</div>
